RENOVORX, INC. (RNXT)
RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer
RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer
Hongli Group Inc. Engages Battery Technology Expert Dr. Phillip A. Medina IV as Independent Technical Advisor for Energy Storage Initiatives
Apogee Enterprises to Acquire Kalwall Companies
Perpetuals to Participate at Upcoming Investor Conference
Completion of Tranche 2 of Placement
Conference call to review the financial statements for Q1 2026 on 1.6.26 at 14:00
Biomerica, Inc. - Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
Formula Systems Reports First Quarter 2026 Financial Results
FIFA World Cup 2026™ Hospitality Sales Program Sets Records, Sees Strong Momentum Ahead of Tournament